vs
Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $38.3M, roughly 1.7× ImmunityBio, Inc.). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs -161.8%, a 204.6% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 0.5%).
Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CIM vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.2M | $38.3M |
| Net Profit | $28.3M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 42.6% | -169.0% |
| Net Margin | 42.8% | -161.8% |
| Revenue YoY | 0.5% | 407.0% |
| Net Profit YoY | 119.3% | -4.7% |
| EPS (diluted) | $0.05 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.2M | $38.3M | ||
| Q3 25 | $65.0M | $32.1M | ||
| Q2 25 | $66.0M | $26.4M | ||
| Q1 25 | $69.2M | $16.5M | ||
| Q4 24 | $65.8M | $7.6M | ||
| Q3 24 | $66.5M | $6.1M | ||
| Q2 24 | $67.3M | — | ||
| Q1 24 | $65.1M | — |
| Q4 25 | $28.3M | $-61.9M | ||
| Q3 25 | $-580.0K | $-67.3M | ||
| Q2 25 | $35.5M | $-92.6M | ||
| Q1 25 | $167.3M | $-129.6M | ||
| Q4 24 | $-146.5M | $-59.2M | ||
| Q3 24 | $136.5M | $-85.7M | ||
| Q2 24 | $56.7M | — | ||
| Q1 24 | $129.5M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 42.6% | -169.0% | ||
| Q3 25 | -0.5% | -173.5% | ||
| Q2 25 | 54.3% | -269.8% | ||
| Q1 25 | — | -390.1% | ||
| Q4 24 | -222.6% | -919.0% | ||
| Q3 24 | — | -1314.3% | ||
| Q2 24 | 84.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 42.8% | -161.8% | ||
| Q3 25 | -0.9% | -209.8% | ||
| Q2 25 | 53.7% | -350.3% | ||
| Q1 25 | 241.7% | -784.9% | ||
| Q4 24 | -222.6% | -783.4% | ||
| Q3 24 | 205.4% | -1404.0% | ||
| Q2 24 | 84.2% | — | ||
| Q1 24 | 198.8% | — |
| Q4 25 | $0.05 | $-0.06 | ||
| Q3 25 | $-0.27 | $-0.07 | ||
| Q2 25 | $0.17 | $-0.10 | ||
| Q1 25 | $1.77 | $-0.15 | ||
| Q4 24 | $-2.06 | $-0.08 | ||
| Q3 24 | $1.39 | $-0.14 | ||
| Q2 24 | $0.41 | — | ||
| Q1 24 | $1.36 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $278.6M | $242.8M |
| Total DebtLower is stronger | $251.5M | — |
| Stockholders' EquityBook value | $2.6B | $-500.5M |
| Total Assets | $15.8B | $501.9M |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.6M | $242.8M | ||
| Q3 25 | $491.5M | $257.8M | ||
| Q2 25 | $250.2M | $153.7M | ||
| Q1 25 | $253.3M | $61.6M | ||
| Q4 24 | $84.0M | $149.8M | ||
| Q3 24 | $97.3M | $130.4M | ||
| Q2 24 | $162.3M | — | ||
| Q1 24 | $169.0M | — |
| Q4 25 | $251.5M | — | ||
| Q3 25 | $251.0M | — | ||
| Q2 25 | $135.2M | — | ||
| Q1 25 | $134.9M | — | ||
| Q4 24 | $134.6M | — | ||
| Q3 24 | $134.4M | — | ||
| Q2 24 | $62.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.6B | $-500.5M | ||
| Q3 25 | $2.6B | $-524.3M | ||
| Q2 25 | $2.6B | $-570.7M | ||
| Q1 25 | $2.6B | $-591.4M | ||
| Q4 24 | $2.5B | $-489.1M | ||
| Q3 24 | $2.7B | $-745.1M | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | — |
| Q4 25 | $15.8B | $501.9M | ||
| Q3 25 | $15.1B | $519.0M | ||
| Q2 25 | $14.9B | $402.1M | ||
| Q1 25 | $13.2B | $303.8M | ||
| Q4 24 | $13.1B | $382.9M | ||
| Q3 24 | $13.7B | $364.6M | ||
| Q2 24 | $13.1B | — | ||
| Q1 24 | $12.5B | — |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-248.9M | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | -8.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-248.9M | $-70.4M | ||
| Q3 25 | $-137.5M | $-68.9M | ||
| Q2 25 | $-7.4M | $-79.7M | ||
| Q1 25 | $48.8M | $-85.9M | ||
| Q4 24 | $205.7M | $-85.1M | ||
| Q3 24 | $41.4M | $-98.8M | ||
| Q2 24 | $69.0M | — | ||
| Q1 24 | $57.3M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 45.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -8.78× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.21× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
